PHARMAVANTY

Ninove ·KBO/BCE: BE 0752.751.474

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	31-08-2025	31 d late	2025-00459694
31-12-2023	31-07-2024	28-08-2024	28 d late	2024-00388739
31-12-2022	31-07-2023	21-08-2023	21 d late	2023-00350362
31-12-2021	31-07-2022	22-08-2022	22 d late	2022-20306339
31-12-2020	31-07-2021	07-07-2021	24 d early	2021-32500329

Line item	Code	2021
Balance sheet, Assets
TOTAL ASSETS	20/58	€59k
Fixed assets	21/28	€33k
Tangible fixed assets	22/27	€33k
Current assets	29/58	€26k
Amounts receivable within one year	40/41	€1k
Cash & bank	54/58	€23k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€59k
Equity	10/15	€27k
Contributions / capital	10/11	€3k
Reserves	13	€24k
Amounts payable	17/49	€33k
Amounts payable after one year	17	€22k
Amounts payable within one year	42/48	€10k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€32k
Operating result	9901	€22k
Financial income	75	€6
Financial charges	65	€581
Result before taxes	9903	€22k
Income taxes	67/77	€5k
Net result for the period	9904	€17k
Result to be appropriated	9905	€17k

Summary